title: Enantiomeric drug development: issues, considerations, and regulatory requirements.
authors.affiliation: Metabolism and Pharmacokinetics, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543, USA.
authors.forename: N R
authors.initials: NR
authors.lastname: Srinivas
authors.forename: R H
authors.initials: RH
authors.lastname: Barbhaiya
authors.forename: K K
authors.initials: KK
authors.lastname: Midha
mesh_terms: D002626:Chemistry, Pharmaceutical; D004341:Drug Evaluation / Q000331:legislation & jurisprudence* / Q000379:methods*; D004353:Drug Evaluation, Preclinical / Q000379:methods; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence / Q000379:methods; D006801:Humans; D013237:Stereoisomerism